Dose converters
If you would like to skip the theory, links to dose converters are at the bottom of this page.
LQ model used
This tool uses linearquadratic (LQ) approach to calculate biologically equivalent dose (BED). Isoeffective dose is described by the following equation:
(1) 
where d and D are fractional and total dose for the treatment. The following tables can be used for the α / β ratios for normal tissues:
Early reactions  Late reactions  



The α / β for welloxygenated carcinomas of head and neck, and lung, are thought to be similar or, sometimes higher, than for earlyresponding normal tissues. Some human tumour types such as melanoma and sarcomas may exhibit low α / β ratios; and earlystage prostate and breast cancer may have α / β ratios perhaps even lower than for late reactions (of normal tissues). Please, find some α / β ratios in the table below:
Tumor  α / β, Gy 

Head and Neck, various Larynx Vocal cord Buccal mucosa Tonsil Nasopharynx 
10.5 14.5 13 6.6 7.2 16 
Skin  8.5 
Prostate  1.1 
Breast  4.6 
Oesophagus  4.9 
Melanoma  0.6 
Liposarcoma  0.4 
For more details you can use, for example, Basic Clinical Radiobiology by Joiner and Kogel, or earlier, Steel's editions.
Often α / β = 10 Gy is used for tumor and α / β = 3 Gy is used for normal tissues if better estimates are not available.
The LQ model is not applicable for hypofractionated treatments. Also, formula (1) does not include certain factors, such as incomplete repair or proliferation.
Biologically equivalent dose
Above we described how to convert one dose regiment to the other but failed to explain what is BED. BED is the theoretical limit of the equivalent dose delivered in small fraction, i.e. when complete repair takes place. The following formula gives BED:
(2) 
Another measure commonly used is equivalent dose in 2 Gy fractions, EQD2, which is given by D2 in formula (1) with d2 = 2 Gy.
Dose converters:
New number of fractions based on new dose per fraction 
New dose per fraction based on new number of fractions 